Overutilization of endoscopic surveillance in nondysplastic Barrett's: too much of a good thing?

PubWeight™: 0.75‹?›

🔗 View Article (PMID 22537646)

Published in Gastroenterology on April 24, 2012

Authors

David A Klibansky1, Stuart R Gordon, Timothy B Gardner

Author Affiliations

1: Section of Gastroenterology and Hepatology, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA.

Articles by these authors

Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med (2009) 10.91

Incomplete polyp resection during colonoscopy-results of the complete adenoma resection (CARE) study. Gastroenterology (2012) 4.13

Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. Gastroenterology (2011) 3.44

MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinoma. Clin Cancer Res (2011) 2.95

Alcohol and smoking as risk factors in an epidemiology study of patients with chronic pancreatitis. Clin Gastroenterol Hepatol (2010) 2.46

The "golden hours" of management in acute pancreatitis. Am J Gastroenterol (2012) 2.26

Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. Arch Intern Med (2009) 2.23

Radiofrequency ablation for long- and ultralong-segment Barrett's esophagus: a comparative long-term follow-up study. Gastrointest Endosc (2013) 2.12

Early fluid resuscitation reduces morbidity among patients with acute pancreatitis. Clin Gastroenterol Hepatol (2011) 1.88

Multicenter approach to recurrent acute and chronic pancreatitis in the United States: the North American Pancreatitis Study 2 (NAPS2). Pancreatology (2008) 1.87

Occlusion rate and complications of plastic biliary stent placement in patients undergoing neoadjuvant chemoradiotherapy for pancreatic cancer with malignant biliary obstruction. J Clin Gastroenterol (2010) 1.77

EUS-guided FNA diagnostic yield of malignancy in solid pancreatic masses: a benchmark for quality performance measurement. Gastrointest Endosc (2007) 1.72

Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis. Nat Genet (2012) 1.63

Direct endoscopic necrosectomy for the treatment of walled-off pancreatic necrosis: results from a multicenter U.S. series. Gastrointest Endosc (2011) 1.44

Type of pain, pain-associated complications, quality of life, disability and resource utilisation in chronic pancreatitis: a prospective cohort study. Gut (2011) 1.35

American Pancreatic Association Practice Guidelines in Chronic Pancreatitis: evidence-based report on diagnostic guidelines. Pancreas (2014) 1.30

Docetaxel/Gemcitabine followed by gemcitabine and external beam radiotherapy in patients with pancreatic adenocarcinoma. Ann Surg Oncol (2005) 1.30

Combined bicarbonate conductance-impairing variants in CFTR and SPINK1 variants are associated with chronic pancreatitis in patients without cystic fibrosis. Gastroenterology (2010) 1.27

Low mortality and high morbidity in severe acute pancreatitis without organ failure: a case for revising the Atlanta classification to include "moderately severe acute pancreatitis". Am J Gastroenterol (2009) 1.20

Treatment of ultralong-segment Barrett's using focal and balloon-based radiofrequency ablation. Surg Endosc (2009) 1.20

Smoking is underrecognized as a risk factor for chronic pancreatitis. Pancreatology (2011) 1.19

Ocular manifestations of hepatitis C virus infection. Curr Opin Ophthalmol (2002) 1.17

Percutaneous radiologic gastrostomy versus percutaneous endoscopic gastrostomy: a comparison of indications, complications and outcomes in 370 patients. Eur J Radiol (2005) 1.17

A comprehensive, case-based review of groove pancreatitis. Pancreas (2009) 1.15

Peginterferon alfa-2b and ribavirin for treatment-refractory chronic hepatitis C. J Hepatol (2005) 1.12

The impact of prior biliary stenting on the accuracy and complication rate of endoscopic ultrasound fine-needle aspiration for diagnosing pancreatic adenocarcinoma. Pancreas (2011) 1.10

Pancreatic cyst prevalence and the risk of mucin-producing adenocarcinoma in US adults. Am J Gastroenterol (2013) 1.08

MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm. Cancer Genet (2013) 1.08

Fecal transplantation: beyond the aesthetic. Gastroenterology (2013) 1.07

The clinical relevance of the increasing incidence of intraductal papillary mucinous neoplasm. Clin Gastroenterol Hepatol (2011) 1.06

Physical and mental quality of life in chronic pancreatitis: a case-control study from the North American Pancreatitis Study 2 cohort. Pancreas (2013) 1.06

Chronic pancreatitis and its effect on employment and health care experience: results of a prospective American multicenter study. Pancreas (2010) 1.05

Screening for pancreatic cancer in a high-risk population with serum CA 19-9 and targeted EUS: a feasibility study. Gastrointest Endosc (2011) 1.00

Endoscopic therapy of necrotizing pancreatitis and pseudocysts. Gastrointest Endosc Clin N Am (2013) 0.97

Effect of initiating a multidisciplinary care clinic on access and time to treatment in patients with pancreatic adenocarcinoma. J Oncol Pract (2010) 0.93

Outcomes of intra-abdominal fungal vs. bacterial infections in severe acute pancreatitis. Am J Gastroenterol (2009) 0.93

Relationship between patient symptoms and endosonographic findings in chronic pancreatitis. Pancreatology (2009) 0.89

Stress ulcer prophylaxis in non-critically ill patients: less may be more. Am J Gastroenterol (2006) 0.88

Interobserver agreement for pancreatic endoscopic ultrasonography determined by same day back-to-back examinations. J Clin Gastroenterol (2011) 0.87

Comparison of differing sedation practice for upper endoscopic ultrasound using expert observational analysis of the procedural sedation. J Patient Saf (2009) 0.83

Spectrum of use and effectiveness of endoscopic and surgical therapies for chronic pancreatitis in the United States. Pancreas (2014) 0.83

Use the Harmless Acute Pancreatitis Score wisely. Clin Gastroenterol Hepatol (2009) 0.80

The impact of time elapsed between endoscopic ultrasound and esophagectomy on concordance of ultrasonographic and pathologic staging of esophageal malignancy. Dig Dis Sci (2011) 0.80

A study of low dose peginterferon alpha-2b with ribavirin for the initial treatment of chronic hepatitis C. Am J Gastroenterol (2006) 0.79

Pancreaticoduodenectomy for the treatment of groove pancreatitis. Dig Dis Sci (2012) 0.79

Clinical Profile, Etiology, and Treatment of Chronic Pancreatitis in North American Women: Analysis of a Large Multicenter Cohort. Pancreas (2016) 0.77

A phase II trial of human secretin infusion for refractory type B pain in chronic pancreatitis. Pancreas (2013) 0.77

Predictors Of Treatment Failure After Radiofrequency Ablation For Intramucosal Adenocarcinoma in Barrett Esophagus: A Multi-institutional Retrospective Cohort Study. Am J Surg Pathol (2016) 0.76

Risk factors for the development of intra-abdominal fungal infections in acute pancreatitis. Pancreas (2015) 0.76

Trimodality therapy for stage II-III carcinoma of the esophagus: a dose-ranging study of concurrent capecitabine, docetaxel, and thoracic radiotherapy. J Thorac Oncol (2013) 0.75

Pancreatic duct compliance after secretin stimulation: a novel endoscopic ultrasound diagnostic tool for chronic pancreatitis. Pancreas (2012) 0.75

The Final Cytopathologic Diagnosis of Initially "Indeterminate" Pancreatic Mass Lesions. Pancreas (2016) 0.75

Response. Gastrointest Endosc (2013) 0.75

Rectal indomethacin for the prevention of post-ERCP pancreatitis: a valuable tool to keep in your back pocket. Gastroenterology (2012) 0.75

Successful retreatment with chemoradiotherapy for local recurrence of pancreatic adenocarcinoma after neoadjuvant therapy and pancreaticoduodenectomy. Gastrointest Cancer Res (2013) 0.75

Considering an investment in precious metals? Time to take stock. Gastrointest Endosc (2010) 0.75

Reported findings on endoscopic ultrasound examinations for chronic pancreatitis: toward establishing an endoscopic ultrasound quality benchmark. Pancreas (2014) 0.75

Islet Cell Yield Following Remote Total Pancreatectomy With Islet Autotransplant is Independent of Cold Ischemia Time. Pancreas (2017) 0.75

Response to Tse and Yuan. Am J Gastroenterol (2013) 0.75

A new treatment algorithm for relapsing autoimmune pancreatitis? Gastroenterology (2013) 0.75

Corrigendum: 2016 ACG Abstracts- Clinical Vignettes/Case Reports - Esophagus. Am J Gastroenterol (2017) 0.75

Management of acute pancreatitis. Expert Rev Gastroenterol Hepatol (2014) 0.75

Influence of baseline hematocrit on traditional calculations of hemoconcentration to predict severity in acute pancreatitis. Pancreas (2008) 0.75

Image of the month. Intraductal papillary mucinous neoplasm. Gastroenterology (2002) 0.75

Abnormal duodenal [HCO3-] following secretin stimulation develops sooner than endocrine insufficiency in minimal change chronic pancreatitis. Pancreas (2012) 0.75

Case of a closed choledochocele with biliary and pancreatic drainage via the accessory duct causing acute pancreatitis. Dig Endosc (2009) 0.75

Expanding indications for pancreatic islet cell transplantation. Curr Opin Gastroenterol (2020) 0.75

The Cost of Surveying Intraductal Papillary Mucinous Neoplasms. Pancreas (2017) 0.75

Clinical challenges and images in GI. Klippel-Trenaunay syndrome. Gastroenterology (2008) 0.75

The effect of neoadjuvant chemoradiation on pancreatic cancer-associated diabetes mellitus. Pancreas (2014) 0.75

Neuroma of the bile duct: a late complication after cholecystectomy. J Gastrointest Surg (2009) 0.75

Narcotic Independence After Pancreatic Duct Stenting Predicts Narcotic Independence After Lateral Pancreaticojejunostomy for Chronic Pancreatitis. Pancreas (2016) 0.75

Novel use of endoscopic ultrasound to diagnose aortoenteric fistula. J Clin Gastroenterol (2007) 0.75

Evidence-based management of necrotizing pancreatitis. Curr Treat Options Gastroenterol (2014) 0.75